Sepetaprost
Drug profile
Also known as: DE-126, ONO-9054, setaneo
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Sepetaprost is a drug catalogued in DrugCentral. It was first approved by the PMDA in 2025. DrugCentral lists 2 molecular targets, including PTGFR and PTGER3. Recorded indications include Glaucoma.
- Molecular targets: PTGFR and PTGER3 (2 listed in DrugCentral).
- Indications: Glaucoma.
- Molecular formula: C26H36F2O6; molecular weight 482.56 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Glaucoma
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Prostaglandin F2-alpha receptor | PTGFR | agonist | EC50 7.65 |
| Prostaglandin E2 receptor EP3 subtype | PTGER3 | agonist | EC50 7.54 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2025-08-25 | PMDA | — | Santen Pharmaceutical Co., Ltd. |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Sepetaprost is on its molecule page.
| Molecular formula | C26H36F2O6 |
|---|---|
| Molecular weight | 482.56 g/mol |
| CAS number | — |
| InChIKey | BKVUSNOUTQMSBE-XCMGCKIWSA-N |
| PubChem CID | 50902259 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Sepetaprost used for?
DrugCentral lists the following indications for Sepetaprost: Glaucoma.
How does Sepetaprost work?
Its molecular targets in DrugCentral include PTGFR (agonist) and PTGER3 (agonist).
When was Sepetaprost first approved?
Sepetaprost was first approved by the PMDA in 2025.
What is the chemical formula of Sepetaprost?
Sepetaprost has the molecular formula C26H36F2O6 and a molecular weight of 482.56 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5805 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL4297633 — compound record and bioactivity
- PubChem CID 50902259 — chemical identifiers
- DrugBank DB12043 — drug record
- FDA UNII 79O7855J4G — substance identity
- UniProt P43088 (PTGFR) — target protein
- UniProt P43115 (PTGER3) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.